Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Susan Wonnacott

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Competitive Binding

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
10
Lunt, George
9
Jones, Ian
9
Albuquerque, Edson
8
Sharples, Christopher
7
Whiteaker, Paul
7
Dajas-Bailador, Federico
6
Barik, Jacques
6
Blagbrough, Ian
6
Gallagher, Timothy
5
Wolstenholme, Adrian
5
Soliakov, L
4
Stolerman, Ian
4
O'Neill, Michael
4
Potter, BV
4
Redfern, Peter

Sign-in to see all Coauthors

Publications

TOP 3
Livingstone Phil D; Wonnacott Susan
Nicotinic acetylcholine receptors and the ascending dopamine pathways.
Quarta Davide; Naylor Christopher G; Barik Jacques; Fernandes Cathy; Wonnacott Susan; Stolerman Ian P
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.
Livingstone Phil D; Srinivasan Jayaraman; Kew James N C; Dawson Lee A; Gotti Cecilia; Moretti Milena; Shoaib Mohammed; Wonnacott Susan
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Susan Wonnacott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Livingstone Phil D; Wonnacott Susan
Nicotinic acetylcholine receptors and the ascending dopamine pathways.
Biochemical pharmacology 2009;78(7):744-55.
2009: Quarta Davide; Naylor Christopher G; Barik Jacques; Fernandes Cathy; Wonnacott Susan; Stolerman Ian P
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.
Psychopharmacology 2009;203(2):399-410.
2009: Livingstone Phil D; Srinivasan Jayaraman; Kew James N C; Dawson Lee A; Gotti Cecilia; Moretti Milena; Shoaib Mohammed; Wonnacott Susan
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.
The European journal of neuroscience 2009;29(3):539-50.
2008: Innocent Neal; Livingstone Phil D; Hone Arik; Kimura Atsuko; Young Tracey; Whiteaker Paul; McIntosh J Michael; Wonnacott Susan
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
The Journal of pharmacology and experimental therapeutics 2008;327(2):529-37.
2008: Dickinson Jane A; Kew James N C; Wonnacott Susan
Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms.
Molecular pharmacology 2008;74(2):348-59.
2008: Abin-Carriquiry J Andrés; Costa Gustavo; Urbanavicius Jessika; Cassels Bruce K; Rebolledo-Fuentes Marco; Wonnacott Susan; Dajas Federico
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
European journal of pharmacology 2008;589(1-3):80-4.
2008: Wonnacott Susan
Smoking cessation 2008.
IDrugs : the investigational drugs journal 2008;11(4):256-9.
2008: Hanrott Katharine; Murray Tracey K; Orfali Zeina; Ward Mark; Finlay Clare; O'Neill Michael J; Wonnacott Susan
Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions.
The European journal of neuroscience 2008;27(5):1086-96.
2008: Wonnacott S
Gates and filters: unveiling the physiological roles of nicotinic acetylcholine receptors in dopaminergic transmission.
British journal of pharmacology 2008;153 Suppl 1():S2-4.
2007: Oliver Jennifer L; Pashmi Ghazaleh; Barnett Paul; Mettens Pascal; Biemans Ralph; Monteyne Philippe; Palmantier Rémi; Gallagher Timothy; Ramaya Sharn; Wonnacott Susan
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
Vaccine 2007;25(42):7354-62.
2007: Sidhpura Nimish; Redfern Peter; Rowley Helen; Heal David; Wonnacott Susan
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
Biochemical pharmacology 2007;74(8):1292-8.
2007: Urbanavicius Jessika; Ferreira Margot; Costa Gustavo; Abin-Carriquiry Juan Andrés; Wonnacott Susan; Dajas Federico
Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum.
Journal of neurochemistry 2007;102(3):723-30.
2007: Sidhpura Nimish; Redfern Peter; Wonnacott Susan
Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
European journal of pharmacology 2007;567(1-2):102-9.
2007: Dickinson Jane A; Hanrott Katharine E; Mok M H Selina; Kew James N C; Wonnacott Susan
Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells.
Journal of neurochemistry 2007;100(4):1089-96.
2007: Nuutinen Saara; Barik Jacques; Jones Ian W; Wonnacott Susan
Differential effects of acute and chronic nicotine on Elk-1 in rat hippocampus.
Neuroreport 2007;18(2):121-6.
2006: Kanakubo Akira; Gray Diane; Innocent Neal; Wonnacott Susan; Gallagher Timothy
The synthesis and nicotinic binding activity of (+/-)-epiquinamide and (+/-)-C(1)-epiepiquinamide.
Bioorganic & medicinal chemistry letters 2006;16(17):4648-51.
2006: Abin-Carriquiry J Andrés; Voutilainen Merja H; Barik Jacques; Cassels Bruce K; Iturriaga-Vásquez Patricio; Bermudez Isabel; Durand Claudia; Dajas Federico; Wonnacott Susan
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
European journal of pharmacology 2006;536(1-2):1-11.
2006: Hanrott Katharine; Gudmunsen Louise; O'Neill Michael J; Wonnacott Susan
6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta.
The Journal of biological chemistry 2006;281(9):5373-82.
2006: Barik Jacques; Wonnacott Susan
Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
Molecular pharmacology 2006;69(2):618-28.
2006: Wonnacott Susan; Barik Jacques; Dickinson Jane; Jones Ian W
Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters.
Journal of molecular neuroscience : MN 2006;30(1-2):137-40.
2006: Jones Ian W; Westmacott Adam; Chan Elcie; Jones Roy W; Dineley Kelly; O'Neill Michael J; Wonnacott Susan
Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes.
Journal of molecular neuroscience : MN 2006;30(1-2):83-4.
2005: Cassels Bruce K; Bermúdez Isabel; Dajas Federico; Abin-Carriquiry J Andrés; Wonnacott Susan
From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research.
Drug discovery today 2005;10(23-24):1657-65.
2005: Barik Jacques; Dajas-Bailador Federico; Wonnacott Susan
Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.
British journal of pharmacology 2005;145(8):1084-92.
2005: Rousseau Stephen J; Jones Ian W; Pullar Ian A; Wonnacott Susan
Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Neuropharmacology 2005;49(1):59-72.
2005: Jones Ian W; Wonnacott Susan
Why doesn't nicotinic ACh receptor immunoreactivity knock out?
Trends in neurosciences 2005;28(7):343-5.
2005: Wonnacott Susan; Sidhpura Nimish; Balfour David J K
Nicotine: from molecular mechanisms to behaviour.
Current opinion in pharmacology 2005;5(1):53-9.
2004: Jones Ian W; Wonnacott Susan
Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(50):11244-52.
2004: Mogg Adrian J; Jones Francis A; Pullar Ian A; Sharples Christopher G V; Wonnacott Susan
Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
Neuropharmacology 2004;47(6):848-59.
2004: Nicke Annette; Wonnacott Susan; Lewis Richard J
Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes.
European journal of biochemistry / FEBS 2004;271(12):2305-19.
2004: Dajas-Bailador Federico; Wonnacott Susan
Nicotinic acetylcholine receptors and the regulation of neuronal signalling.
Trends in pharmacological sciences 2004;25(6):317-24.
2004: Jones Ian W; Barik Jacques; O'Neill Michael J; Wonnacott Susan
Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors.
Journal of neuroscience methods 2004;134(1):65-74.
2003: Hejmadi M V; Dajas-Bailador F; Barns S M; Jones B; Wonnacott S
Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes.
Molecular and cellular neurosciences 2003;24(3):779-86.
2003: Dajas-Bailador Federico A; Heimala Kaisa; Wonnacott Susan
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Molecular pharmacology 2003;64(5):1217-26.
2003: Karig Gunter; Large Jonathan M; Sharples Christopher G V; Sutherland Andrew; Gallagher Timothy; Wonnacott Susan
Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity.
Bioorganic & medicinal chemistry letters 2003;13(17):2825-8.
2003: Hahn Britta; Sharples Christopher G V; Wonnacott Susan; Shoaib Mohammed; Stolerman Ian P
Attentional effects of nicotinic agonists in rats.
Neuropharmacology 2003;44(8):1054-67.
2003: Sutherland Andrew; Gallagher Timothy; Sharples Christopher G V; Wonnacott Susan
Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165.
The Journal of organic chemistry 2003;68(6):2475-8.
2003: Richardson C E; Morgan J M; Jasani B; Green J T; Rhodes J; Williams G T; Lindstrom J; Wonnacott S; Peel S; Thomas G A O
Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis.
QJM : monthly journal of the Association of Physicians 2003;96(1):57-65.
2002: Sharples Christopher G V; Karig Gunter; Simpson Graham L; Spencer James A; Wright Emma; Millar Neil S; Wonnacott Susan; Gallagher Timothy
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
Journal of medicinal chemistry 2002;45(15):3235-45.
2002: Mogg Adrian J; Whiteaker Paul; McIntosh J Michael; Marks Michael; Collins Allan C; Wonnacott Susan
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
The Journal of pharmacology and experimental therapeutics 2002;302(1):197-204.
2002: Da Cunha Claudio; Angelucci Miriam Elizabeth Mendes; Canteras Newton S; Wonnacott Susan; Takahashi Reinaldo N
The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.
Cellular and molecular neurobiology 2002;22(3):227-37.
2002: Dajas-Bailador Federico A; Mogg Adrian J; Wonnacott Susan
Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores.
Journal of neurochemistry 2002;81(3):606-14.
2002: Dajas-Bailador F A; Soliakov L; Wonnacott S
Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones.
Journal of neurochemistry 2002;80(3):520-30.
2002: Ridley Diana L; Pakkanen Jukka; Wonnacott Susan
Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells.
British journal of pharmacology 2002;135(4):1051-9.
2001: Jones I W; Bolam J P; Wonnacott S
Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones.
The Journal of comparative neurology 2001;439(2):235-47.
2001: Ridley D L; Rogers A; Wonnacott S
Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
British journal of pharmacology 2001;133(8):1286-95.
2001: Richardson C E; Morgan J M; Jasani B; Green J T; Rhodes J; Williams G T; Lindstrom J; Wonnacott S; Thomas G A; Smith V
Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit.
Gastroenterology 2001;121(2):350-7.
2001: Lind R J; Hardick D J; Blagbrough I S; Potter B V; Wolstenholme A J; Davies A R; Clough M S; Earley F G; Reynolds S E; Wonnacott S
[3H]-Methyllycaconitine: a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors.
Insect biochemistry and molecular biology 2001;31(6-7):533-42.
2001: Soliakov L; Wonnacott S
Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes..
British journal of pharmacology 2001;132(3):785-91.
2000: Dajas-Bailador F A; Lima P A; Wonnacott S
The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism.
Neuropharmacology 2000;39(13):2799-807.
2000: Kaiser S; Wonnacott S
alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
Molecular pharmacology 2000;58(2):312-8.
2000: Sharples C G; Kaiser S; Soliakov L; Marks M J; Collins A C; Washburn M; Wright E; Spencer J A; Gallagher T; Whiteaker P; Wonnacott S
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(8):2783-91.
2000: Wonnacott S; Kaiser S; Mogg A; Soliakov L; Jones I W
Presynaptic nicotinic receptors modulating dopamine release in the rat striatum.
European journal of pharmacology 2000;393(1-3):51-8.
1999: Whiteaker P; Davies A R; Marks M J; Blagbrough I S; Potter B V; Wolstenholme A J; Collins A C; Wonnacott S
An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.
The European journal of neuroscience 1999;11(8):2689-96.
1999: Davies A R; Hardick D J; Blagbrough I S; Potter B V; Wolstenholme A J; Wonnacott S
Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.
Neuropharmacology 1999;38(5):679-90.
1998: Whiteaker P; Sharples C G; Wonnacott S
Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Molecular pharmacology 1998;53(5):950-62.
1998: Eastham H M; Lind R J; Eastlake J L; Clarke B S; Towner P; Reynolds S E; Wolstenholme A J; Wonnacott S
Characterization of a nicotinic acetylcholine receptor from the insect Manduca sexta.
The European journal of neuroscience 1998;10(3):879-89.
1998: Kaiser S A; Soliakov L; Harvey S C; Luetje C W; Wonnacott S
Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices.
Journal of neurochemistry 1998;70(3):1069-76.
1997: Whiteaker P; Sharples C G; Wonnacott S
Pharmacology of nicotinic acetylcholine receptor (nAChR) upregulation in the transfected cell line, M10.
Biochemical Society transactions 1997;25(3):550S.
1997: Davies A R; Hardick D J; Blagbrough I S; Potter B V; Wolstenholme A J; Wonnacott S
Structure-activity studies of bicyclic and tricyclic analogues of methyllycaconitine.
Biochemical Society transactions 1997;25(3):545S.
1997: Rogers A T; Wonnacott S
Differential upregulation of alpha 7 and alpha 3 subunit-containing nicotinic acetylcholine receptors in rat hippocampal and PC12 cell cultures.
Biochemical Society transactions 1997;25(3):544S.
1997: Marshall D L; Redfern P H; Wonnacott S
Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats.
Journal of neurochemistry 1997;68(4):1511-9.
1997: Samuel N; Wonnacott S; Lindstrom J; Futerman A H
Parallel increases in [alpha-125I]bungarotoxin binding and alpha 7 nicotinic subunit immunoreactivity during the development of rat hippocampal neurons in culture.
Neuroscience letters 1997;222(3):179-82.
1997: Wonnacott S
Presynaptic nicotinic ACh receptors.
Trends in neurosciences 1997;20(2):92-8.
1996: Hardick D J; Blagbrough I S; Cooper G; Potter B V; Critchley T; Wonnacott S
Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding.
Journal of medicinal chemistry 1996;39(24):4860-6.
1996: Wilkie G I; Hutson P; Sullivan J P; Wonnacott S
Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.
Neurochemical research 1996;21(9):1141-8.
1996: Soliakov L; Wonnacott S
Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated [3H]dopamine release from rat striatal synaptosomes.
Journal of neurochemistry 1996;67(1):163-70.
1996: Marshall D; Soliakov L; Redfern P; Wonnacott S
Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum.
Neuropharmacology 1996;35(11):1531-6.
1995: Soliakov L; Gallagher T; Wonnacott S
Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes.
Neuropharmacology 1995;34(11):1535-41.
1995: Whiteaker P; Garcha H S; Wonnacott S; Stolerman I P
Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.
British journal of pharmacology 1995;116(3):2097-105.
1995: Amar M; Thomas P; Wonnacott S; Lunt G G
A nicotinic acetylcholine receptor subunit from insect brain forms a non-desensitising homo-oligomeric nicotinic acetylcholine receptor when expressed in Xenopus oocytes.
Neuroscience letters 1995;199(2):107-10.
1995: Barrantes G E; Murphy C T; Westwick J; Wonnacott S
Nicotine increases intracellular calcium in rat hippocampal neurons via voltage-gated calcium channels.
Neuroscience letters 1995;196(1-2):101-4.
1995: Hardick D J; Cooper G; Scott-Ward T; Blagbrough I S; Potter B V; Wonnacott S
Conversion of the sodium channel activator aconitine into a potent alpha 7-selective nicotinic ligand.
FEBS letters 1995;365(1):79-82.
1995: Molloy L; Wonnacott S; Gallagher T; Brough P A; Livett B G
Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells.
European journal of pharmacology 1995;289(3):447-53.
1995: Rogers A T; Wonnacott S
Nicotine-induced upregulation of alpha bungarotoxin (alpha Bgt) binding sites in cultured rat hippocampal neurons.
Biochemical Society transactions 1995;23(1):48S.
1995: Barrantes G E; Rogers A T; Lindstrom J; Wonnacott S
alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha 7 subunits and up-regulation by chronic nicotine treatment.
Brain research 1995;672(1-2):228-36.
1994: Aplin A; Wonnacott S
Interaction of p-aminophenyldichloroarsine, an arsenical with specificity for vicinal cysteines, with [3H]cytisine binding sites in rat brain membranes.
Biochemical pharmacology 1994;48(3):473-7.
1994: Barrantes G E; Westwick J; Wonnacott S
Nicotinic acetylcholine receptors in primary cultures of hippocampal neurons: pharmacology and Ca++ permeability.
Biochemical Society transactions 1994;22(3):294S.
1993: Amar M; Thomas P; Johnson C; Lunt G G; Wonnacott S
Agonist pharmacology of the neuronal alpha 7 nicotinic receptor expressed in Xenopus oocytes.
FEBS letters 1993;327(3):284-8.
1993: Sanderson E M; Drasdo A L; McCrea K; Wonnacott S
Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific.
Brain research 1993;617(2):349-52.
1993: Wilkie G I; Hutson P H; Stephens M W; Whiting P; Wonnacott S
Hippocampal nicotinic autoreceptors modulate acetylcholine release.
Biochemical Society transactions 1993;21(2):429-31.
1993: Garcha H S; Thomas P; Spivak C E; Wonnacott S; Stolerman I P
Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist.
Psychopharmacology 1993;110(3):347-54.
1992: Drasdo A; Caulfield M; Bertrand D; Bertrand S; Wonnacott S
Methyl lycaconitine: A novel nicotinic antagonist.
Molecular and cellular neurosciences 1992;3(3):237-43.
1992: Alkondon M; Pereira E F; Wonnacott S; Albuquerque E X
Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
Molecular pharmacology 1992;41(4):802-8.
1992: Wonnacott S; Swanson K L; Albuquerque E X; Huby N J; Thompson P; Gallagher T
Homoanatoxin: a potent analogue of anatoxin-A.
Biochemical pharmacology 1992;43(3):419-23.
1991: Wonnacott S; Jackman S; Swanson K L; Rapoport H; Albuquerque E X
Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
The Journal of pharmacology and experimental therapeutics 1991;259(1):387-91.
1991: Swanson K L; Aronstam R S; Wonnacott S; Rapoport H; Albuquerque E X
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
The Journal of pharmacology and experimental therapeutics 1991;259(1):377-86.
1991: Wonnacott S
The relevance of receptor binding studies to tobacco research.
British journal of addiction 1991;86(5):537-41.
1991: Wonnacott S
Neuronal nicotinic receptors: functional correlates of ligand binding sites.
Biochemical Society transactions 1991;19(1):121-4.
1991: Thorne B; Wonnacott S; Dunkley P R
Isolation of hippocampal synaptosomes on Percoll gradients: cholinergic markers and ligand binding sites.
Journal of neurochemistry 1991;56(2):479-84.
1990: Rowell P P; Wonnacott S
Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes.
Journal of neurochemistry 1990;55(6):2105-10.
1990: Wonnacott S; Thorne B
Separation of pre- and post-synaptic receptors on Percoll gradients.
Biochemical Society transactions 1990;18(5):885-6.
1990: Ward J M; Cockcroft V B; Lunt G G; Smillie F S; Wonnacott S
Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites.
FEBS letters 1990;270(1-2):45-8.
1990: Ramoa A S; Alkondon M; Aracava Y; Irons J; Lunt G G; Deshpande S S; Wonnacott S; Aronstam R S; Albuquerque E X
The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.
The Journal of pharmacology and experimental therapeutics 1990;254(1):71-82.
1990: Rapier C; Lunt G G; Wonnacott S
Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation.
Journal of neurochemistry 1990;54(3):937-45.
1989: Rozental R; Aracava Y; Scoble G T; Swanson K L; Wonnacott S; Albuquerque E X
Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine.
The Journal of pharmacology and experimental therapeutics 1989;251(2):395-404.
1989: Wonnacott S; Irons J; Rapier C; Thorne B; Lunt G G
Presynaptic modulation of transmitter release by nicotinic receptors.
Progress in brain research 1989;79():157-63.
1988: Cairns N J; Wonnacott S
[3H](-)nicotine binding sites in fetal human brain.
Brain research 1988;475(1):1-7.
1988: Rapier C; Lunt G G; Wonnacott S
Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation.
Journal of neurochemistry 1988;50(4):1123-30.
1988: Macallan D R; Lunt G G; Wonnacott S; Swanson K L; Rapoport H; Albuquerque E X
Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems.
FEBS letters 1988;226(2):357-63.
1987: Aracava Y; Deshpande S S; Swanson K L; Rapoport H; Wonnacott S; Lunt G; Albuquerque E X
Nicotinic acetylcholine receptors in cultured neurons from the hippocampus and brain stem of the rat characterized by single channel recording.
FEBS letters 1987;222(1):63-70.
1987: Rapier C; Wonnacott S; Lunt G G; Albuquerque E X
The neurotoxin histrionicotoxin interacts with the putative ion channel of the nicotinic acetylcholine receptors in the central nervous system.
FEBS letters 1987;212(2):292-6.
1982: Wonnacott S; Harrison R; Lunt G
Immunological cross-reactivity between the alpha-bungarotoxin-binding component from rat brain and nicotinic acetylcholine receptor.
Journal of neuroimmunology 1982;3(1):1-13.

Sign-in to see more